High doses of purified stem cells cause early hematopoietic recovery in syngeneic and allogeneic hosts.

In humans, autologous transplants derived from bone marrow (BM) usually engraft more slowly than transplants derived from mobilized peripheral blood. Allogeneic BM transplants show a further delay in engraftment and have an apparent requirement for donor T cells to facilitate engraftment. In mice, T...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Yayımlandı:	J Clin Invest
Asıl Yazarlar:	Uchida, N, Tsukamoto, A, He, D, Friera, A M, Scollay, R, Weissman, I L
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	American Society for Clinical Investigation 1998
Konular:	Research Article
Online Erişim:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC508646/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9486965/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI1681
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

High doses of purified stem cells cause early hematopoietic recovery in syngeneic and allogeneic hosts.

Benzer Materyaller